Cigna Group (CI) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-05-13

Key Insights

Cigna reaffirms its 2026 full-year adjusted income from operations guidance of at least $30.35 per share, indicating management confidence in meeting previously communicated targets despite ongoing market uncertainties.
The company emphasizes that adjusted income from operations excludes net investment gains/losses, amortization of intangibles, and special items, which could mask material impacts on actual GAAP earnings and represents a non-GAAP metric with significant unpredictable reconciliation items.
Management acknowledges inability to provide forward-looking reconciliation to GAAP net income due to unpredictable investment results and special items, suggesting potential material variance between non-GAAP guidance and actual shareholder results.
The filing is a routine Regulation FD disclosure confirming previously announced guidance rather than announcing material new developments, indicating no major changes to business outlook or strategic direction.

Want the newest filings?

This analysis covers the filing from 2026-05-13. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-04-30

Cigna filed a routine 8-K to report Q1 2026 earnings results for the period ended March 31, 2026, with the actual financial details contained in the press release exhibit rather than disclosed in the filing itself.
The filing was signed by Ann M. Dennison, Executive Vice President and Chief Financial Officer, indicating standard corporate governance procedures were followed for earnings announcements.
This is a standard earnings disclosure filing with no material agreements, leadership changes, or extraordinary events indicated, suggesting normal operational reporting rather than significant corporate developments.

Filed: 2026-04-27

Strong shareholder participation with 89.97% quorum (237.2M of 263.7M shares represented), indicating healthy investor engagement with the company.
All 12 director nominees were elected with substantial support; CEO David M. Cordani received 213M votes for but also the most opposition (6.4M against) among directors, suggesting some investor concerns about leadership.
Executive compensation advisory vote passed with 92.1% support (201.7M for vs 17.4M against), indicating strong shareholder approval of pay practices despite the CEO opposition votes.
PricewaterhouseCoopers LLP reappointed as auditor with 91.2% approval (216M for), demonstrating continued confidence in current auditing arrangements.
Shareholder proposal for written consent rights was defeated (104.9M for vs 114.2M against), with management maintaining preferred governance structure by narrow margin.

Filed: 2026-03-03

Cigna Group announced that Brian C. Evanko will succeed David M. Cordani as the new Chief Executive Officer effective July 1, 2026.
The company reaffirmed its 2026 financial guidance, including consolidated adjusted income from operations of at least $30.25 per share, Evernorth pre-tax adjusted income from operations of at least $6.9 billion, and Cigna Healthcare pre-tax adjusted income from operations of at least $4.5 billion.
The company made several changes to its Board of Directors, including the election of Eric J. Foss as the new Lead Independent Director and changes to the composition of the Board's committees.

Filed: 2026-02-27

Cigna Group reaffirmed its projected full year 2026 consolidated adjusted income from operations on a per share basis of at least $30.25 per share, indicating strong financial performance.
The company highlighted that adjusted income from operations is a key financial metric used to assess profitability, as it excludes certain non-recurring items and provides insights into the underlying business trends.
The report noted that management is unable to provide a reconciliation of adjusted income from operations to shareholders' net income on a forward-looking basis due to the inability to predict certain components, suggesting uncertainty around some financial factors.

Filed: 2026-02-05

Cigna Group announced Q4 2025 financial results, reporting revenue and earnings growth compared to the prior year period.
The company provided full-year 2026 guidance, indicating continued strong performance and growth outlook.
No significant leadership changes or material agreements were disclosed in the 8-K filing.

Other reports for Cigna Group

Insider Trading Quarterly Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.